This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2023 Jan;165(1):27.

doi: 10.1007/s15006-023-2259-7.

Neues Nasenspray zur Akuttherapie bei Migräne

[Article in German]

Hans-Christoph Diener¹

Affiliations

Affiliation

¹ Institut für Medizinische Informatik, Biometrie und Epidemiologie (IMIBE), Medizinische Fakultät der Universität Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Deutschland.

PMID: 36648657
DOI: 10.1007/s15006-023-2259-7

Review

Neues Nasenspray zur Akuttherapie bei Migräne

[Article in German]

Hans-Christoph Diener. MMW Fortschr Med. 2023 Jan.

. 2023 Jan;165(1):27.

doi: 10.1007/s15006-023-2259-7.

Author

Hans-Christoph Diener¹

Affiliation

¹ Institut für Medizinische Informatik, Biometrie und Epidemiologie (IMIBE), Medizinische Fakultät der Universität Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Deutschland.

PMID: 36648657
DOI: 10.1007/s15006-023-2259-7

No abstract available

PubMed Disclaimer

Comment on

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial.
Croop R, Madonia J, Stock DA, Thiry A, Forshaw M, Murphy A, Coric V, Lipton RB. Croop R, et al. Headache. 2022 Oct;62(9):1153-1163. doi: 10.1111/head.14389. Epub 2022 Oct 14. Headache. 2022. PMID: 36239038 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer